Oxidative stress and the pathogenesis of neurodegenerative disorders

Ashley Reynolds1, Chad Laurie, R Lee Mosley

  • 1Department of Pharmacology and Experimental Neuroscience, Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.

Insights

Microglia-derived toxins, especially reactive oxygen species, drive neurodegenerative diseases by causing oxidative stress. New therapies are urgently needed to reduce neuroinflammation and protect brain cells from damage.

Area of Science:

  • Neuroscience
  • Pathology
  • Toxicology

Background:

  • Microglia-derived inflammatory neurotoxins, particularly reactive oxygen species, are key contributors to neurodegenerative diseases like Alzheimer's and Parkinson's.
  • The central nervous system's limited ability to counteract oxidative stress exacerbates neuronal damage.
  • Disease progression involves environmental factors, mitochondrial dysfunction, protein misfolding, and impaired protein clearance, all impacting glial function.

Purpose of the Study:

  • To highlight the critical role of microglia-derived neurotoxins in neurodegeneration.
  • To emphasize the link between oxidative stress, neuroinflammation, and disease mechanisms.
  • To underscore the urgent need for novel therapeutic strategies targeting neuroinflammation and oxidative stress.

Main Methods:

  • Literature review and synthesis of existing research on neuroinflammation and neurodegeneration.
  • Analysis of the contribution of reactive oxygen species and other factors to disease pathogenesis.
  • Examination of the impact of aging populations on the prevalence of neurodegenerative diseases.

Main Results:

  • Reactive oxygen species are identified as a principal neurotoxin driving neurodegeneration.
  • Multiple factors including environmental cues, mitochondrial dysfunction, and protein aggregation accelerate disease.
  • Glial dysfunction is implicated in accelerating the pace of neurodegenerative diseases.

Conclusions:

  • Understanding the interplay between disease progression, free radical formation, and neuroinflammation is crucial for developing effective treatments.
  • Novel therapeutic strategies are urgently required to combat age-related neurodegenerative diseases by reducing neuroinflammation and protecting neurons from oxidative stress.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...